• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXHL2100060 Tirzepatide注射液 tirzepatide Injection Chemical Drugs(1) Import Drug Application 2021-02-25 Eli Lilly and Company Eli Lilly & Company In Review 2021-02-24 view
JXHL2100059 Tirzepatide注射液 tirzepatide Injection Chemical Drugs(1) Import Drug Application 2021-02-25 Eli Lilly and Company Eli Lilly & Company In Review 2021-02-24 view
JXHL2100063 Tirzepatide注射液 tirzepatide Injection Chemical Drugs(1) Import Drug Application 2021-02-25 Eli Lilly and Company Eli Lilly & Company In Review 2021-02-24 view
JXHL2100058 Tirzepatide注射液 tirzepatide Injection Chemical Drugs(1) Import Drug Application 2021-02-25 Eli Lilly and Company Eli Lilly & Company In Review 2021-02-24 view
JXHL2100062 Tirzepatide注射液 tirzepatide Injection Chemical Drugs(1) Import Drug Application 2021-02-25 Eli Lilly and Company Eli Lilly & Company In Review 2021-02-24 view
JXHL2100061 Tirzepatide注射液 tirzepatide Injection Chemical Drugs(1) Import Drug Application 2021-02-25 Eli Lilly and Company Eli Lilly & Company In Review 2021-02-24 view
JXSS2100007 Ramucirumab注射液 ramucirumab Injection Biological Products(3.1) Import Drug Application 2021-01-21 Eli Lilly and Company Eli Lilly & Company In Review 2021-01-20 view
JXSS2100006 Ramucirumab注射液 ramucirumab Injection Biological Products(3.1) Import Drug Application 2021-01-21 Eli Lilly and Company Eli Lilly & Company In Review 2021-01-20 view
JXHB2000067 Lasmiditan(LY573144)半琥珀酸盐片 lasmiditan succinate Tablet Chemical Drugs(1) Supplementary Application 2021-01-01 Eli Lilly and Company Eli Lilly & Company In Review 2021-01-01 view
JTS2000051 Ramucirumab ramucirumab Injection Biological Products Disposable Import Drug Application 2020-11-06 Eli Lilly and Company Eli Lilly & Company Certificate Issued 2020-11-30 view
JTS2000052 Ramucirumab ramucirumab Injection Biological Products Disposable Import Drug Application 2020-11-06 Eli Lilly and Company Eli Lilly & Company Certificate Issued 2020-11-30 view
JYSB2000514 依奇珠单抗注射液 ixekizumab Injection Biological Products Supplementary Application 2020-10-15 Eli Lilly and Company Eli Lilly & Company Certificate Issued 2021-01-05 view
JYSB2000378 依奇珠单抗注射液 ixekizumab Injection Biological Products Supplementary Application 2020-08-21 Eli Lilly and Company Eli Lilly & Company Filed 2020-09-02 view
JXHB2000006 Baricitinib (LY3009104)片 baricitinib Tablet Chemical Drugs(2.4) Supplementary Application 2020-08-06 Eli Lilly and Company Eli Lilly & Company In Review 2020-08-05 view
JXHB2000005 Baricitinib (LY3009104)片 baricitinib Tablet Chemical Drugs(2.4) Supplementary Application 2020-08-06 Eli Lilly and Company Eli Lilly & Company In Review 2020-08-05 view
JXHL2000201 Tirzepatide注射液 tirzepatide Injection Chemical Drugs(1) Import Drug Application 2020-07-06 Eli Lilly and Company Eli Lilly & Company In Review 2020-07-04 view
JXHL2000200 Tirzepatide注射液 tirzepatide Injection Chemical Drugs(1) Import Drug Application 2020-07-06 Eli Lilly and Company Eli Lilly & Company In Review 2020-07-04 view
JXHL2000199 Tirzepatide注射液 tirzepatide Injection Chemical Drugs(1) Import Drug Application 2020-07-06 Eli Lilly and Company Eli Lilly & Company In Review 2020-07-04 view
JXHL2000203 Tirzepatide注射液 tirzepatide Injection Chemical Drugs(1) Import Drug Application 2020-07-06 Eli Lilly and Company Eli Lilly & Company In Review 2020-07-04 view
JXHL2000198 Tirzepatide注射液 tirzepatide Injection Chemical Drugs(1) Import Drug Application 2020-07-06 Eli Lilly and Company Eli Lilly & Company In Review 2020-07-04 view